The microfluidic device market was valued at USD 15.38 Billion in 2025. It is expected to grow at a CAGR of 19.80% during the forecast period of 2026-2035 and attain a market value of USD 93.65 Billion by 2035. Microfluidic device technology has revolutionized drug discovery, and diagnostic testing and the development of these advanced technologies including microfabrication. This has impacted the patent landscape.
The expanding applications of microfluidic device including diagnostics, drug delivery, point of care testing, DNA sequencing, among others has fueled the patent filings across multiple applications.
The growing advancements in microfluidic technologies such as enhanced device design, development in fabrication technologies, and advanced fluid handling capabilities have led to increased patent filings to protect these technologies.
The number of patent filings is increasing in several jurisdictions, particularly in the United States, and Europe. This surge can be attributed to healthcare companies, universities and academic institutions investing heavily in research to improve microfluidic device technologies.
The Microfluidic Device Patent Landscape report provides a comprehensive and in-depth analysis of the patents in the industry. The key sections captured in the report for microfluidic devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within microfluidic device technologies.
Microfluidic technology has multiple benefits as miniaturized devices allows processing and analyzing of small sample volumes, in the range of μL to pL. These devices exploit the physical and chemical properties of liquids and gases at a microscale level. Moreover, these devices allow the analysis and use of less volume of samples. These advancements in the field have led to increased patent filings by the companies to protect their intellectual property rights.
Microfluidic device involves the control and manipulation of fluids, within channels, typically ranging from tens to hundreds of micrometres in dimension. These devices are known for their small scale, which allows the handling of small amounts of fluids. This miniaturization offers advantages including faster reaction times, reduced reagent consumption, and increased sensitivity in analyses.
Microfluidic devices offer multiple benefits over conventionally sized systems. Microfluidics allow the analysis of less volume of samples, chemicals and reagents. The applications of microfluidic devices include separation and manipulation of cells, DNA analysis, nanoparticle transport in blood, diagnostics, and biopharmaceutical production among others. The development of innovative technologies for microfluidic systems promotes commercialization of microfluidic devices and patent filing of these advanced technologies.
Advances in Microfabrication Techniques, such as Lithography, Micro-Electro-Mechanical Systems (MEMS) and 3D are Expected to Boost the Patent Industry Growth
Fluigent has developed a series of microfluidic systems based on its patented FASTAB technology. This technology overcomes the fluid volume manipulation issues which is present in current microfluidic control systems. This advanced technology features pressure driven flow control which allows a pulseless flow and greater responsiveness. Similarly, Dolomite Microfluidic Device has also launched an innovative 3D fluidics printer named Fluidic Factory. It is the first commercial 3D printer for fluidically sealed devices such as connectors, chips, fluid manifolds, valves, and medical devices. Companies are actively filing patents to protect their innovations which is significantly impacting the patent landscape.
Expanding Pharmaceutical and Biotechnology Applications Leading to a Rise in Patent Filing
The microfluidic device industry is growing due to expanding applications in pharma and biotech including point-of-care diagnostics, and drug delivery systems. Moreover, microfluidic platforms are used to detect biomarkers which are associated with various diseases. It facilitates early detection of disease and effective monitoring of treatment.
The research applications of microfluidic devices include the study of nanoparticle transport in blood and antibiotic drug-resistant bacteria. The expanding application signifies the need for patent registration. Companies are filing patents to protect inventions and impact the patent landscape. For instance, the number of patents granted increased from 5,511 in 2022 to 3552 in 2023.
The report will cover the following sections in detail:
Market Breakup by Technology
The breakup based on technology includes lab-on-chip, micro-propulsion, micro-thermal technologies, organ-on-chips, and others. The production of microfluidic devices is achieved through multiple fabrication methods. The four most common techniques are soft lithography, 3D bioprinting, photolithography and injection moulding.
The detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for microfluidic device patents, having around 90,000+ patents. The presence of an established legal framework and advanced research and development initiatives contribute to the patent landscape for the region.
Among the players with microfluidic device patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Life Technologies Corporation, a ThermoFisher company founded in 2008, was formed by the merger of Invitrogen Corporation and Applied Biosystems Inc. The company holds several patents in the field of microfluidic devices.
Standard BioTools Inc. offers analytical mass cytometry systems for flow cytometry and tissue imaging. The company also offers associated assays and reagents, automated genomic analysis instruments and multiple microfluidic arrays. The company holds multiple patents related to microfluidic technologies. Their device includes a plurality of sets of first chambers and a plurality of sets of second chambers.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Agilent Technologies Inc., and IBM, among others.
The microfluidic device patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
Global Microfluidic Device Market
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| Scope of the Report | Details |
| Analysis by Technology |
|
| Key Players Mentioned |
|
| Geographies Covered |
|
Mini Report
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share